Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.
about
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits.A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future ProspectsNeuroprotective Transcription Factors in Animal Models of Parkinson DiseaseStem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver InjuryUsing stem cells and iPS cells to discover new treatments for Parkinson's diseaseDirected differentiation of embryonic stem cells using a bead-based combinatorial screening methodPhysiological characterisation of human iPS-derived dopaminergic neuronsDynamic Trk and G Protein Signalings Regulate Dopaminergic Neurodifferentiation in Human Trophoblast Stem CellsGenomics and bioinformatics of Parkinson's diseaseAutologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques.Solving the puzzle of Parkinson's disease using induced pluripotent stem cells.Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potentialDirected differentiation of forebrain GABA interneurons from human pluripotent stem cells.Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian ratsImpact of induced pluripotent stem cells on the study of central nervous system diseaseMicroRNA-based promotion of human neuronal differentiation and subtype specification.Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.Trophic and proliferative effects of Shh on motor neurons in embryonic spinal cord culture from wildtype and G93A SOD1 mice.Stem cell technology for neurodegenerative diseases.Comparison and optimization of hiPSC forebrain cortical differentiation protocols.Specification of neuronal and glial subtypes from human pluripotent stem cellsSuccessful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.Cell-based therapies for Parkinson disease—past insights and future potential.Retinoic acid induced the differentiation of neural stem cells from embryonic spinal cord into functional neurons in vitro.Progress on stem cell research towards the treatment of Parkinson's disease.DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction.Specification of midbrain dopamine neurons from primate pluripotent stem cells.Excessive Wnt/beta-catenin signaling promotes midbrain floor plate neurogenesis, but results in vacillating dopamine progenitors.FGF8 is Essential for Functionality of Induced Neural Precursor Cell-derived Dopaminergic NeuronsMolecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.Drug discovery in Parkinson's disease-Update and developments in the use of cellular models.The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson's disease model.Induced pluripotent stem cells as a next-generation biomedical interface.Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.Progress and prospects for genetic modification of nonhuman primate models in biomedical research.FoxO3a contributes to the reprogramming process and the differentiation of induced pluripotent stem cells
P2860
Q24339508-BDA42CEF-306B-4780-B219-15A0CEFE46EEQ24598809-C85F9A8D-2EC3-463E-AAA2-2D23F3B177FEQ26746033-6A4A2134-A15A-4E81-8BF4-8DCF6A5AB02BQ26765693-469E0A9C-1B50-4BED-8255-FAB426D82921Q26781923-8A778852-D992-4E1A-A429-9308B726DE81Q26825867-1D038E72-FD50-478D-9511-10C1B2A444D1Q27316236-20A7F62B-D6D4-4641-9205-43C05532C50AQ27324718-390690DB-B729-4523-95C0-A36D11B11CD3Q28551183-82E735C6-64CD-454B-BDF5-70039DC9438DQ28727855-B346B5F0-27AC-46FC-98A9-5360D4AA0C58Q30530883-328D93D0-6ABD-4157-9BA4-E94FAD10FEAEQ33358637-1D02C0BB-EAFE-48BC-81D8-57FCF9A4DC72Q33921142-C7BB18F9-DEA4-46B8-89CB-0B746E2BC639Q33999627-10DE1DD8-5365-4DFD-9909-4120E64B4DF2Q34115609-8DEF7E46-04A8-4028-B2CF-E917BF38A527Q34161356-5EF56CE6-02C0-4FEF-84B4-6ADFAACDDE3EQ34634519-A289B0E7-CD71-407B-AE59-853F497F7AA7Q34845881-CAAA34F6-2791-4C2A-B6F8-25E25EAA9195Q35015937-1F0C8A31-CB94-4199-890A-FEC9F8D7EF38Q35224202-1BA7EA7A-C672-48B3-8CF1-A80E58DC405BQ35233519-185C3A61-6EB3-48AD-AAA4-E93D17FF82EEQ35501624-1C285EF0-61F8-4632-989E-E1992EE7F668Q35711351-203D243E-B91F-4D84-8C22-33E37CA293DEQ35736662-E834E167-ECE3-4500-8DE9-B0FBC5D5029AQ36014303-2677991A-A832-477F-B9F5-7DDF78ED6620Q36084830-43990985-ED9C-4639-9B72-3C58B848476DQ36104501-4D1E2CF4-5844-4434-BDF8-49DD04E94438Q36117009-E0A4C427-234E-43A8-9FD5-9B79C6A009CCQ36248773-EC71FD9E-90BC-4E75-83AF-4E121290E6CBQ36295494-F523C26E-6E79-4D17-995B-3789D582FC59Q36373006-9E39B586-8B66-453E-848F-8EDB7A892977Q36680414-B5ADD9F1-7C88-4984-8D82-C6AF6DA98430Q36695546-24339C8F-8993-4280-BF9D-AD1E7206B6FDQ36787847-C15B72EE-2BA5-4B85-820B-3CB22AB7DFBDQ36882491-72988E96-4889-4A09-B235-C49C63B84250Q37055318-1AED7374-CDE2-4AE1-A0D0-8043A04FC7D8Q37179338-12C38E5A-DEAC-42D4-954E-19C35B26230DQ37200879-3A625831-3583-421E-8E86-8CC05FBDF118Q37271259-5E3D9D90-503B-48D8-96F3-506288BC9D78Q37293528-EE288818-76EE-41C5-B32A-D8F53D23D761
P2860
Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Differentiation of human ES an ...... ionalization by retinoic acid.
@ast
Differentiation of human ES an ...... ionalization by retinoic acid.
@en
Differentiation of human ES an ...... ionalization by retinoic acid.
@nl
type
label
Differentiation of human ES an ...... ionalization by retinoic acid.
@ast
Differentiation of human ES an ...... ionalization by retinoic acid.
@en
Differentiation of human ES an ...... ionalization by retinoic acid.
@nl
prefLabel
Differentiation of human ES an ...... ionalization by retinoic acid.
@ast
Differentiation of human ES an ...... ionalization by retinoic acid.
@en
Differentiation of human ES an ...... ionalization by retinoic acid.
@nl
P2093
P2860
P1476
Differentiation of human ES an ...... gionalization by retinoic acid
@en
P2093
Alexandra Blak
Alyssa Yow
Eduardo Perez-Torres
Elizabeth Marlow
Gunnar Hargus
Kristen Lee
Michela Deleidi
Teresia Osborn
P2860
P304
P356
10.1016/J.MCN.2010.06.017
P577
2010-07-24T00:00:00Z